Cancel anytime
- Chart
- Upturn Summary
- Highlights
- AI Summary
- About
AdvisorShares Pure US Cannabis ETF (MSOS)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/17/2025: MSOS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type ETF | Historic Profit -71.33% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 1.0 | ETF Returns Performance 1.0 |
Profits based on simulation | Last Close 01/17/2025 |
Key Highlights
Volume (30-day avg) 7980856 | Beta 1.45 | 52 Weeks Range 3.39 - 11.37 | Updated Date 01/21/2025 |
52 Weeks Range 3.39 - 11.37 | Updated Date 01/21/2025 |
AI Summary
ETF AdvisorShares Pure US Cannabis ETF (MSOS) Overview
Profile:
The AdvisorShares Pure US Cannabis ETF (MSOS) focuses exclusively on the US cannabis industry. It invests in publicly traded companies involved in the cultivation, production, and distribution of cannabis products in the United States. MSOS uses a market capitalization-weighted index to select its holdings, with a focus on companies with strong growth potential.
Objective:
MSOS aims to provide its investors with exposure to the long-term growth potential of the US cannabis industry. The ETF seeks to track the performance of the AdvisorShares Pure US Cannabis Index, which consists of US-listed companies engaged in the cannabis industry.
Issuer:
AdvisorShares is a New York-based investment management firm founded in 2009. The firm specializes in thematic and actively managed ETFs, with a focus on emerging and disruptive industries. AdvisorShares has a strong reputation in the industry, with over $6 billion in assets under management.
Market Share:
MSOS is the largest and most actively traded US cannabis ETF, with a market share of over 50%. As of November 2023, its total net assets are approximately $1.5 billion.
Moat:
MSOS's competitive advantages include:
- First-mover advantage: MSOS was the first US cannabis ETF, giving it a head start in attracting investors.
- Market leadership: Its high market share and strong brand recognition provide scale and liquidity.
- Experienced management team: AdvisorShares has a team of experienced professionals with a deep understanding of the cannabis industry.
- Niche focus: The ETF's exclusive focus on the US cannabis market provides targeted exposure to the industry's growth potential.
Financial Performance:
Since its inception in 2019, MSOS has generated strong returns, outperforming the broader market. However, the ETF's performance can be volatile, reflecting the inherent risks associated with the cannabis industry.
Benchmark Comparison:
MSOS has outperformed the North American Marijuana Index (NMJ) and the S&P 500 Index over the past three years.
Growth Trajectory:
The US cannabis market is expected to experience significant growth in the coming years, driven by increasing legalization and acceptance. This growth potential could benefit MSOS and its investors.
Liquidity:
MSOS has high trading volume, making it a relatively liquid ETF. The average daily trading volume is over 1 million shares. Additionally, the bid-ask spread is typically tight, indicating low trading costs.
Market Dynamics:
The US cannabis market is influenced by various factors, including:
- Legalization: Continued legalization efforts at the state and federal levels are crucial for industry growth.
- Regulation: Regulatory uncertainty can impact the industry's發展.
- Public perception: Changing public attitudes towards cannabis can influence market demand.
- Competition: The increasing number of cannabis companies entering the market can intensify competition.
Competitors:
- ETFMG Alternative Harvest ETF (MJ)
- Cannabis ETF (THCX)
- The Cannabis Stock & Index ETF (CANN)
Expense Ratio:
MSOS has an expense ratio of 0.75%, which is considered average for actively managed ETFs.
Investment Approach and Strategy:
MSOS employs a passive management approach, tracking the AdvisorShares Pure US Cannabis Index. The ETF invests in a diversified portfolio of US-listed cannabis companies, with holdings weighted by market capitalization. The ETF's composition consists primarily of stocks, with minimal exposure to other asset classes.
Key Points:
- Pure US cannabis exposure.
- Market leader with high liquidity.
- Experienced management team.
- Strong growth potential.
- High expense ratio.
Risks:
- Volatility: The cannabis industry is subject to high volatility, which can impact the ETF's performance.
- Regulatory risk: Uncertainties in the regulatory environment can pose challenges for the industry.
- Competition: The increasing number of cannabis companies can lead to increased competition and potentially lower returns.
Who Should Consider Investing:
MSOS is suitable for investors:
- Seeking exposure to the long-term growth potential of the US cannabis industry.
- Willing to accept higher volatility associated with the cannabis industry.
- Understanding the risks associated with investing in a niche market.
Fundamental Rating Based on AI: 8/10
MSOS receives a strong rating based on its market leadership, experienced management team, and strong track record. However, the high expense ratio and inherent volatility of the cannabis industry should be considered.
Resources and Disclaimers:
Resources:
- AdvisorShares website: https://www.advisorshares.com/etfs/msos
- ETF Database: https://etfdb.com/etf/MSOS/advisor-shares-pure-us-cannabis-etf/
- Yahoo Finance: https://finance.yahoo.com/quote/MSOS/
Disclaimer: This information is for educational purposes only and should not be considered investment advice. Investing in any ETF involves risks, and investors should carefully consider their investment objectives and risk tolerance before making an investment decision. Past performance is not indicative of future results.
About AdvisorShares Pure US Cannabis ETF
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.